Ulcerative Colitis (UC) Clinical Trial
Official title:
A Phase I/II Randomized, Controlled, Clinical Trial for Assessment of the Safety and Efficacy of Allogeneic Adipose Mesenchymal Stem Cells in Moderate to Severe Ulcerative Colitis Patients
Ulcerative colitis is a form of inflammatory bowel disease characterized by diffuse inflammation of the colonic mucosa. It affects the rectum and extends proximally along a variable length of the colon. Ulcerative colitis is a chronic condition with a relapsing remitting course. Mesenchymal stem cells (MSCs) are a subset of adult stem cells residing in many tissues, including bone marrow (BM), adipose tissue, umbilical cord blood. Recent experimental findings have shown the ability of MSCs to home to damaged tissues and to produce paracrine factors with anti-inflammatory properties, potentially resulting in reduction of inflammation and functional recovery of the damaged tissues. The purpose of our study is to evaluate safety and efficacy of the intracolonic injection by using a colonoscope of allogeneic adipose MSCs in patients with moderate active ulcerative colitis.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02819635 -
A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT05960864 -
Chinese Spondyloarthritis Inception Cohort (CESPIC)
|
||
| Not yet recruiting |
NCT05316220 -
A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis
|
Phase 3 | |
| Completed |
NCT02345733 -
Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis
|
Phase 4 | |
| Terminated |
NCT02217722 -
Use of the Ulcerative Colitis Diet for Induction of Remission
|
N/A | |
| Completed |
NCT02778464 -
Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease
|
||
| Completed |
NCT01971814 -
Early Serum Infliximab Levels in Severe Ulcerative Colitis.
|
Phase 1 | |
| Completed |
NCT03223012 -
Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service
|
||
| Active, not recruiting |
NCT03456206 -
Chronic Inflammatory Disease, Lifestyle and Risk of Disease
|
||
| Completed |
NCT04254783 -
A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
|
Phase 1 | |
| Completed |
NCT03398148 -
A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis
|
Phase 2/Phase 3 | |
| Withdrawn |
NCT02087878 -
A Blood and Tissue Sample Collection Study of Patients Who Have Inflammatory Bowel Disease, Who Have Been Treated With Adalimumab and Who Developed Hepatosplenic T-Cell Lymphoma
|
||
| Completed |
NCT02065622 -
Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis
|
Phase 3 | |
| Completed |
NCT03695185 -
A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy
|
Phase 2 | |
| Completed |
NCT02108821 -
Fecal Microbiota Transplantation in Pediatric Patients
|
Phase 1 | |
| Terminated |
NCT03758443 -
Efficacy & Safety of TD-1473 in Ulcerative Colitis
|
Phase 2/Phase 3 | |
| Completed |
NCT01364896 -
Anal Human Papillomavirus in Inflammatory Bowel Disease Study
|
||
| Terminated |
NCT03920254 -
TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study
|
Phase 2/Phase 3 | |
| Recruiting |
NCT01277419 -
German Spondyloarthritis Inception Cohort
|
||
| Recruiting |
NCT05377580 -
A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis
|
Phase 2 |